Multicenter Clinical Observation of Guilonghulou Coating Agent in Prevention and Treatment of Thrombosis of Autologous Arteriovenous Fistula in Hemodialysis Patients
- Conditions
- Failure of autologous arteriovenous fistula
- Registration Number
- ITMCTR1900002410
- Lead Sponsor
- the Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1) Patients who meet the diagnostic criteria of uremia stage of chronic renal failure and have been treated with hemodialysis for 3 months or more; (2) Patients who have undergone autologous arteriovenous fistula surgery and met the maturity criteria of arteriovenous fistula in the first edition of Chinese consensus on vascular access for hemodialysis in 2014, and who have begun to puncture arteriovenous fistula for hemodialysis; (3) Blood flow of internal fistula can meet the criteria. The hemodialysis blood flow of patients was more than 250ml/min, the age of patients was between 18 and 80 years old, and the gender was not limited. (4) Informed consent to participate in the study and sign the informed consent.
(1) Mental disorders, cognitive impairment, unable to cooperate with the study smoothly; (2) Coagulation dysfunction, with a significant bleeding tendency; (3) Autoimmune deficiency; (4) Allergic constitution or allergic to a variety of drugs; and (5) Poor compliance.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method B-mode Ultrasound of Blood Vessels;Kidney function;
- Secondary Outcome Measures
Name Time Method iver function;Routine blood test;